Division of Hematology and Oncology
Monday – Friday
8:30 a.m. – 5:00 p.m.
Contact our appointment line at 202-444-2223 for the availability of your specific doctor and the type of service you require.
Use the link above to search for these suggested keywords:
– Myelodysplastic syndrome
More clinical trials are available on NIH’s national clinical trial database.
You will be redirected to our clinical partner, MedStar Health.
About the Cancer
Georgetown Lombardi is committed to providing you with the most current information and resources available on
- Leukemias, including, but not limited to: chronic lymphocytic, chronic myelogenous, acute lymphoblastic, acute myeloid, hairy cell leukemia, and myelodysplastic/myeloproliferative diseases
- Lymphoma cancers, including, but not limited to: leukemia, multiple myeloma, Hodgkin’s disease and non-Hodgkin’s
Current information about all leukemias, incidence and survival statistics, treatment options, causes and prevention, coping strategies, clinical trials, and research, are available online from the National Cancer Institute at the National Institutes of Health.
Current information about lymphoma cancers, incidence and survival statistics, treatment options, causes and prevention, coping strategies, clinical trials, and research, are available online from the National Cancer Institute at the National Institutes of Health.
What We Offer
Our team uses state-of-the-art treatments and comprehensive supportive services to provide you the best care possible.
- Patient and Family Resources
- Clinical Trials: Through our clinical partnership with MedStar Health, Georgetown Lombardi is pleased to offer you access to cutting-edge clinical trials.
Georgetown Lombardi’s world-renowned research faculty are discovering cancer risk factors, designing effective prevention strategies, and learning how to detect cancers earlier. They are developing and testing the cancer treatments of tomorrow — targeted therapies that will improve both survival and quality of life. They are making progress toward the ultimate goal: to eradicate cancer.